Sitagliptin PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Sitagliptin PCD pharma franchise company in India, offering 14 Sitagliptin formulations in tablet form, covering both plain strengths and widely prescribed fixed-dose combinations. All products are manufactured at WHO-GMP certified facilities with DCGI-approved compositions, giving franchise partners a strong anti-diabetic portfolio.
What is Sitagliptin?
Sitagliptin is an oral anti-diabetic drug of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It blocks the DPP-4 enzyme that normally degrades incretin hormones such as GLP-1 and GIP, so incretin levels rise, insulin release increases in a glucose-dependent manner and glucagon secretion falls. It is used to improve glycaemic control in adults with type 2 diabetes mellitus. Pharmacological details are available on PubChem.
Therapeutic Applications of Sitagliptin
Sitagliptin is indicated as an adjunct to diet and exercise in type 2 diabetes mellitus, used as monotherapy where metformin is not tolerated, and more commonly as add-on therapy with metformin, sulfonylureas or SGLT2 inhibitors. It is prescribed principally by diabetologists and endocrinologists, and in very large volumes by consulting physicians and general practitioners.
Why Sitagliptin is a High-Potential Molecule for Distributors
Sitagliptin's patent expiry in India reset its commercial profile: prices fell, generic competition opened up, and the molecule moved out of the specialist-only bracket into everyday second-line prescribing after metformin. Its clinical advantages drive that shift, since it is weight-neutral and carries a low intrinsic risk of hypoglycaemia, which makes physicians comfortable prescribing it to elderly patients and to those who cannot tolerate sulfonylureas. Diabetes is lifelong, so every conversion becomes a permanent monthly reorder, and the fixed-dose combination formats let a distributor hold several SKUs of the same molecule in one territory.
Why Choose Cafoli Lifecare
We offer real district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and a complete promotional support package including visual aids, samples, prescription pads, MR bags and doctor gifts. More than 1000+ partners across India work with Cafoli Lifecare.
References
- PubChem – Sitagliptin compound record
- MedlinePlus – Sitagliptin drug information
- PubMed – clinical literature on Sitagliptin
Our formulations of Sitagliptin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: